@Article{,
AUTHOR = {Jean-Nicolas Cornu, Hashim Hashim, Frank Van Der Aa,
Cosimo De Nunzio, Valentina Garcia Perez,
Roseanne Ferreira, Dean S. Elterman},
TITLE = {How I Do It: Transcutaneous tibial nerve stimulation TENSI+ system},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {30},
YEAR = {2023},
NUMBER = {6},
PAGES = {11756--11761},
URL = {http://www.techscience.com/CJU/v30n6/59661},
ISSN = {1488-5581},
ABSTRACT = {Overactive bladder (OAB) is a common condition that
significantly impacts the quality of life (QoL), well
being and daily functioning for both men and women.
Among various treatments, peripheral tibial nerve
stimulation (PTNS) emerges as an effective third-line
treatment for OAB symptoms, with options for either a
percutaneous approach (P-PTNS) or by transcutaneous
delivery (T-PTNS). Recent studies have shown negligible
differences between P-PTNS and T-PTNS efficacy in alleviating urinary urgency and frequency and QoL
improvement and, overall no difference in efficacy over
antimuscarinic regimens. The TENSI+ system offers a
cutting-edge transcutaneous approach, allowing patients
to self-administer treatment conveniently at home with
electrical stimulation delivery through surface electrodes. It
stands out for its ease of preparation, tolerability, and high
levels of patient satisfaction. Prospective multicentric data
highlights TENSI+ to be an effective and safe treatment
for lower urinary tract symptoms with high treatment
adherence at 3 months. This paper aims to familiarize
readers with the TENSI+ system, current studies, device
assembly, operation, and treatment recommendations.},
DOI = {}
}